| 1 |
Tielemans MM, van Boekel GAJ, van Gelder T, et al. Immunosuppressive drugs and the gastrointestinal tract in renal transplant patients[J]. Transplant Rev (Orlando), 2019, 33(2):55-63.
|
| 2 |
Patil AD, Saxena NG, Thakare SB, et al. Diarrhea after kidney transplantation: a study of risk factors and outcomes[J]. J Postgrad Med, 2023, 69(4):205-214.
|
| 3 |
Gabarre P, Loens C, Tamzali Y, et al. Immunosuppressive therapy after solid organ transplantation and the gut microbiota: bidirectional interactions with clinical consequences[J]. Am J Transplant, 2022,22(4):1014-1030.
|
| 4 |
Singh M, Heinceilman M. Disseminated nontuberculous mycobacterium presenting as chronic diarrhea and wasting[J]. J Investig Med High Impact Case Rep, 2022,10:23247096221101860.
|
| 5 |
王於尘,苗芸. 肾移植术后腹泻的管理[J]. 器官移植,2023,14(2):220-226.
|
| 6 |
Zhu LJ, Lin H, Wu XT, et al. Analysis of risk factors and prognosis of diarrhea after renal transplantation[J]. Technol Health Care, 2024,32(4):2069-2080.
|
| 7 |
Echenique IA, Penugond S, Stosor V, et al. Diagnostic yields in solid organ transplant recipients admitted with diarrhea[J]. Clin Infect Dis,2015,60(5):729-737.
|
| 8 |
Hu J, Liu D, Liao G, et al. Fecal microbiota transplantation alleviates immunosuppressant-associated diarrhea and recurrent urinary tract infection in kidney transplant recipients: a retrospective analysis[J]. Gut Pathog, 2025, 17(1):28.
|
| 9 |
Zhao YJ, Wen JQ, Cheng K, et al. Late, severe, noninfectious diarrhea after renal transplantation: high-risk factors, therapy, and prognosis[J]. Transplant Proc, 2013, 45(6):2226-2232.
|
| 10 |
马葵芬,吕军好,余献平,等. 肾移植围手术期腹泻发生情况及危险因素分析[J/OL]. 中华移植杂志:电子版,2021,15(2):77-80.
|
| 11 |
陈虹,范铁艳,邱爽,等. 实体器官移植术后腹泻的深度解析[J/OL]. 实用器官移植电子杂志,2021,9(1):56.
|
| 12 |
Sonambekar A, Mehta V, Desai D, et al. Diarrhea in kidney transplant recipients: etiology and outcome[J]. Indian J Gastroenterol, 2020, 39(2):141-146.
|
| 13 |
Andrews R, Samad MSA, Chimtalapudi T, et al. Sapovirus-associated diarrhea in renal transplant patient treated without altering immunosuppression[J]. Indian J Nephrol, 2025, 35(1):101-103.
|
| 14 |
Bentata Y. Tacrolimus: 20 years of use in adult kidney transplantation. What we should know about its nephrotoxicity[J]. Artif Organs, 2020, 44(2):140-152.
|
| 15 |
袁智辉,杨麒臻,贾磊,等. 尸体肾移植受者术后围术期腹泻的影响因素分析[J].陆军军医大学学报,2023, 45(14):1556-1561.
|
| 16 |
李梦卿,王雪,张凌鹏,等.肾移植受者药物相关性腹泻及他克莫司浓度异常波动分析[J/OL].实用器官移植电子杂志,2023, 11(2):152-155.
|
| 17 |
Gras J, Abdel-Nabey M, Dupont A, et al. Clinical characteristics, risk factors and outcome of severe Norovirus infection in kidney transplant patients: a case-control study[J]. BMC Infect Dis, 2021, 21(1):351.
|
| 18 |
连美,李迁兴,边玉凤,等.肾移植受者腹泻危险因素的Meta分析[J].循证护理,2024, 10(16):2875-2880.
|
| 19 |
Soliman K, Calimlim IK, Perry A, et al. Evolving trends in immunosuppression use and cytomegalovirus infection risk over the past decade in kidney transplantation[J]. Transpl Infect Dis, 2024, 26(5): e14318.
|
| 20 |
孙雯,郭宏波,解泽林,等.肾移植患者术后腹泻的相关因素分析[J].北京大学学报(医学版), 2013, 45(5):779-781.
|
| 21 |
中华医学会器官移植学分会. 中国肾脏移植受者消化系统并发症临床诊疗指南[J].器官移植,2024, 15(4):497-508.
|
| 22 |
Nair SN, Bhaskaran A, Chandorkar A, et al. Noroviral diarrhea in solid organ transplant recipients: an analysis of interventions and outcomes[J]. Clin Transplant, 2023, 37(2):e14855.
|
| 23 |
Rippl M, Burkhard-Meier A, Schönermarck U, et al. Sapovirus: an emerging pathogen in kidney transplant recipients? [J]. Infection, 2024, 52(5):1831-1838.
|
| 24 |
Mouchli MA, Singh S, Boardman L, et al. Natural history of established and de novo inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis[J]. Inflamm Bowel Dis, 2018, 24:1074-1081.
|
| 25 |
Loucif Y, Mackenzie C, Tselikmann O, et al. Infectious diarrhea in kidney transplant recipients[J]. Cureus, 2025, 17(4): e82194.
|
| 26 |
Bunnapradist S, Neri L, Wong W, et al. Incidence and risk factors for diarrhea following kidney transplantation and association with graft loss and mortality[J]. Am J Kidney Dis, 2008, 51(3):478-486.
|
| 27 |
Pilch NA, Bowman LJ, Taber DJ. Immunosuppression trends in solid organ transplantation: the future of individualization, monitoring, and management[J]. Pharmacotherapy, 2021, 41(1):119-131.
|
| 28 |
Angarone M, Snydman DR; AST ID Community of Practice. Diagnosis and management of diarrhea in solid-organ transplant recipients:guidelines from the American Society of Transplantation Infectious Diseases Community of Practice[J]. Clin Transplant, 2019, 33(9):e13550.
|
| 29 |
焦娇,刘文天. 高脂饮食通过菌群代谢产物对肠道稳态影响的研究进展[J].中华临床营养杂,2021, 29(2):114-122.
|
| 30 |
Chen R, Fu Z, Feng Z, et al. Association between atherogenic index of plasma and chronic diarrhea: a cross-sectional study of the NHANES 2005-2010[J]. BMC Gastroenterol, 2025, 25(1):201.
|
| 31 |
Mohamed ME, Saqr A, Staley C, et al. Pharmacomicrobiomics: immunosuppressive drugs and microbiome interactions in transplantation[J]. Transplantation, 2024, 108(9):1895-1910.
|
| 32 |
Aref A, Sharma A, Halawa A. Smoking in renal transplantation; facts beyond myth[J]. World J Transplant, 2017, 7(2):129-133.
|